Save and Improve Lives

Researchers who study the flu posing.

April 22, 2026

At Mizzou’s influenza center, researchers are developing better flu treatments

The NextGen Center for Influenza and Emerging Infectious Diseases is expanding to advance studies on how the virus spreads — and how to stop it.

James Stannard standing in front of a computer screen.

April 20, 2026

Sterilizing surgical implants with neutrons could reduce infections

Mizzou researchers have created a new way to kill bacteria that gets trapped within surgical implants.

Dave Arnold collaborating with others in a lab.

April 14, 2026

Mizzou’s bench-to-bedside efforts support a new drug for a neuromuscular disorder with no cure

The drug, ignaseclant, helped people with Charcot-Marie-Tooth disease in a clinical trial at Mizzou’s NextGen Precision Health building.

Columns on the quad.

April 6, 2026

Mizzou roaring with momentum after record $553 million in research expenditures

Breakthroughs in agriculture, health care, energy and technology fuel Mizzou’s research growth.

Scientists at research reactor

March 24, 2026

DOE and MURR secure critical radioisotope supply chain for medical imaging

The University of Missouri Research Reactor is now the only domestic supplier of gadolinium-153 through a new agreement with the Department of Energy.

March 13, 2026

Mizzou Giving Day surpasses 3,000 gifts for student success and statewide impact

24-hour surge of philanthropy supports scholarships, research and Missouri communities.

Vials of Lu-177 with MURR labels

March 10, 2026

MURR makes NCA Lu-177 available worldwide

Expanded supply will enable researchers and industry to purchase GMP no-carrier-added Lutetium-177 directly from the reactor.

Frank Booth on a treadmill.

March 5, 2026

Moving research forward one step at a time

This Mizzou Giving Day, learn how Frank Booth’s generosity is helping the next generation of scientists keep research, and themselves, moving.

Smita Saxena in the NextGen building.

Feb. 26, 2026

Mizzou researcher applies novel delivery method to treat ALS symptoms

New therapy bypasses the blood-brain barrier to successfully deliver a neuroprotective molecule.

Ben Casterline in his clinic.

Feb. 24, 2026

Mizzou researchers, MU Extension outreach help those with alpha-gal syndrome

The red meat allergy caused by lone star tick bite is on the rise in Missouri and beyond.

Subscribe to

Show Me Mizzou

Stay up-to-date with the latest news by subscribing to the Show Me Mizzou newsletter.

Subscribe